Abstract 43: Discovery of ARV-110, a first in class androgen receptor degrading PROTAC for the treatment of men with metastatic castration resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Abstract 43: Discovery of ARV-110, a first in class androgen receptor degrading PROTAC for the treatment of men with metastatic castration resistant prostate cancer

Published:2021-07-01 Issue: Volume: Page:
ISSN:
Container-title:Experimental and Molecular Therapeutics
language:
Short-container-title:

Author:

Snyder Lawrence B.,Neklesa Taavi K.,Chen Xin,Dong Hanqing,Ferraro Caterina,Gordon Deborah A.,Macaluso Jennifer,Pizzano Jennifer,Wang Jing,Willard Ryan R.,Vitale Nicholas,Peck Ron,Moore Marcia Dougan,Crews Craig M.,Houston John,Crew Andrew P.,Taylor Ian

Publisher

American Association for Cancer Research

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteolysis Targeting Chimeras (PROTACs): An Innovative Strategy for Targeted Protein Degradation and Disease Treatment;International Journal of Drug Discovery and Pharmacology;2024-08-26

2. PROTACing the androgen receptor and other emerging therapeutics in prostate cancer;Expert Review of Anticancer Therapy;2024-07-22

3. Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer;Journal of Medicinal Chemistry;2024-07-11

4. Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia;Journal of Medicinal Chemistry;2024-07-08

5. Discovery of an Azabicyclo[2.1.1]hexane Piperazinium Salt and Its Application in Medicinal Chemistry via a Rearrangement;Organic Letters;2024-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP